Skip to main content

Coronavirus situation at the University of Eastern Finland

Timo Myöhänen.

Preventing cell death in the brain calls for a new perspective on drug development

In the future, a growing number of neurodegenerative diseases could ideally be treated with the same drug, says Timo Myöhänen, the University of Eastern Finland’s newly appointed Professor of Pharmacology and Drug Development. The target of such a drug could be, for example, the PREP enzyme, which affects several factors underlying cell death in the brain.

Drug development should focus on targets that have the potential to affect several disease mechanisms at the same time.

Timo Myöhänen

Professor of Pharmacology and Drug Development

For further information, please contact:

Profile picture: Timo Myöhänen

Timo Myöhänen